Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3978795 | Bulletin du Cancer | 2011 | 7 Pages |
Abstract
Radiotherapy allows locoregional control with systemic impact in some indications. Technologic advances decrease the dose received by normal tissues leading to a low crude number of late side effects near to 5%. Intrinsic radiosensitivity are still of interest in this context of high level of technology and optimized treatments. Assays of radiosensitivity are detailed in this article arguing the negative results but also the perspectives.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Jérôme Lacombe, Jérôme Solassol, Jean-Pierre Pouget, Mickael Coelho, David Azria,